CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 95 enrolled
Drug / intervention
ExactVudevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04981223
NCT04981223N/ACompleted
CompareCT.gov

Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging

Stanford University·interventional·Posted Jul 28, 2021·Updated May 28, 2026

In Brief

A clinical study evaluating ExactVu for Prostate Cancer. Completed, enrolled 95 participants across 1 site.

Detailed Summary

The goal of this study is to use a clinical micro-ultrasound to systematically image the prostate before biopsy or surgery. The images from the ultrasound system will be saved and compared to other imaging modalities and pathology in order to develop better tools.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 28, 2021
Enrollment StartApr 1, 2022
Primary CompletionJan 26, 2024
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 4.9 years ago

Interventions

ExactVudevice

clinical micro-ultrasound, imaging Device, Manufacturer; Exact Imaging